Last updated on February 2019

The Effect of Ganglion Sphenopalatine Block (GSP-block) Versus Placebo on Postdural Puncture Headache

Brief description of study

The purpose of this study is to evaluate the effect of the ganglion sphenopalatine block (GSP block) on postdural puncture headache.

Detailed Study Description

Adult patients with postdural puncture headache will be enrolled in the study. The patients will be randomised to receive a ganglion sphenopalatine block (GSP-block) with either local anesthetic (lidocaine + ropivacaine) or placebo (isotone NaCl).

Primary outcome is hyperactivity in the sphenopalatine ganglion assessed by pain intensity (0-100mm on a visual analogue scale, VAS) of the postdural headache in standing position 30 minutes after block.

If the patients in the timeframe of 1 hour to 1 week after block does not achieve remission (VAS <30mm while standing) they will be offered a "rescue GSP-block" defined as a new GSP-block with "open-label" local anesthetic and if continued lack of remission at least 1 hour thereafter then an epidural blood patch will be offered.

Clinical Study Identifier: NCT03652714

Contact Investigators or Research Sites near you

Start Over

Pia T Jæger, PhD

Rigshospitalet, University of Copenhagen
Copenhagen, Denmark
  Connect »

Christian S Meyhoff, PhD

Bispebjerg and Frederiksberg Hospital, University of Copenhagen
Copenhagen, Denmark
  Connect »

Kim Wildgaard, PhD

Herlev Hospital, University of Copenhagen
Herlev, Denmark
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.